HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasmid-mediated antimicrobial resistance in Haemophilus pleuropneumoniae.

Abstract
Haemophilus pleuropneumoniae, isolated from the lungs of pig, was resistant to ampicillin, streptomycin, and sulfadiazine. This isolate, SD-1, possessed 1 plasmid (pVM105) coded for resistance to ampicillin and sulfadiazine, and the other (pVM104) for resistance to streptomycin and sulfadiazine. A 2nd isolate of H pleuropneumoniae, SD-2, recovered from a pig in a different outbreak of porcine pleuropneumonia, was resistant to streptomycin and sulfadiazine. These resistance determinants were on 1 plasmid (pVM106). All 3 patients were nontransmissible and small (pVM105 = 3.6 x 10(6) daltons, pVM104 and pVM106 = 2.3 x 10(6) daltons. The basis for resistance to ampicillin, encoded on plasmid pVM105, was due to a beta-lactamase. This beta-lactamase was highly active on penicillin G and ampicillin, moderately active on cephalothin, and inactive on oxacillin, indicating a TEM type of beta-lactamase.
AuthorsD C Hirsh, L D Martin, M C Libal
JournalAmerican journal of veterinary research (Am J Vet Res) Vol. 43 Issue 2 Pg. 269-72 (Feb 1982) ISSN: 0002-9645 [Print] United States
PMID7046533 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Sulfadiazine
  • Ampicillin
  • Streptomycin
Topics
  • Ampicillin (pharmacology)
  • Animals
  • Anti-Bacterial Agents (pharmacology)
  • Conjugation, Genetic
  • Disease Outbreaks (veterinary)
  • Escherichia coli (genetics)
  • Haemophilus (drug effects, genetics)
  • Haemophilus Infections (microbiology, veterinary)
  • Mycoplasma Infections (veterinary)
  • Pleuropneumonia, Contagious (microbiology)
  • R Factors
  • Streptomycin (pharmacology)
  • Sulfadiazine (pharmacology)
  • Swine
  • Swine Diseases (microbiology)
  • Transformation, Bacterial

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: